Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms

被引：0

作者：

Xie, Zhuoer ^{[1
]}

Chen, Evan C. C. ^{[2
,3
]}

Mendez, Lourdes M. ^{[4
,5
]}

Komrokji, Rami ^{[1
]}

Zeidan, Amer M. ^{[4
,5
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL USA

[2] Dana Farber Canc Inst, Dept Med Oncol, Adult Leukemia Program, Boston, MA USA

[3] Harvard Med Sch, Boston, MA USA

[4] Yale Univ, Yale Canc Ctr, Dept Internal Med, Sect Hematol,Sch Med, 37 Coll St,First Floor, New Haven, CT 06510 USA

[5] Yale Univ, Smilow Canc Hosp, Sch Med, 37 Coll St,First Floor, New Haven, CT 06510 USA

来源：

CANCER JOURNAL | 2023年 / 29卷 / 03期

关键词：

AML; CCUS; CHIP; CMUS; MDS; SOMATIC MUTATIONS; RISK; COMMON; CHIP; PREVALENCE; DYNAMICS; CELLS; MDS;

D O I：

10.1097/PPO.0000000000000656

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Clonal hematopoiesis (CH) confers a high risk of aging-related diseases and hematologic malignancy. There are still significant knowledge gaps in identifying high-risk patients with CH and managing such patients. In this review, we focus on 3 areas: (1) the natural history of CH; (2) the risks of progression of CH, including CH of indeterminate potential, clonal cytopenia of undetermined significance, and therapy-related CH, to myeloid malignancy; and (3) the challenges and unmet needs of CH management and research.

引用

页码：130 / 137

页数：8

共 50 条

[41] A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agents
Jan Philipp Bewersdorf
Rory M. Shallis
Elad Sharon
Silvia Park
Rahul Ramaswamy
Caroline E. Roe
Jonathan M. Irish
Anne Caldwell
Wei Wei
Abdulraheem Yacoub
Yazan F. Madanat
Joshua F. Zeidner
Jessica K. Altman
Olatoyosi Odenike
Swaroopa Yerrabothala
Tibor Kovacsovics
Nikolai A. Podoltsev
Stephanie Halene
Richard F. Little
Richard Piekarz
Steven D. Gore
Tae Kon Kim
Amer M. Zeidan
Annals of Hematology, 2024, 103 : 105 - 116
[42] Mutation spectrum, expression profiling, and prognosis evaluation of Fanconi anemia signaling pathway genes for 4259 patients with myelodysplastic syndromes or acute myeloid leukemia
Lixian Chang
Li Zhang
Beibei Zhao
Xuelian Cheng
Yang Wan
Ranran Zhang
Weiping Yuan
Xingjie Gao
Xiaofan Zhu
BMC Medical Genomics, 16
[43] Mutation spectrum, expression profiling, and prognosis evaluation of Fanconi anemia signaling pathway genes for 4259 patients with myelodysplastic syndromes or acute myeloid leukemia
Chang, Lixian
Zhang, Li
Zhao, Beibei
Cheng, Xuelian
Wan, Yang
Zhang, Ranran
Yuan, Weiping
Gao, Xingjie
Zhu, Xiaofan
BMC MEDICAL GENOMICS, 2023, 16 (01)
[44] Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation
Koenecke, Christian
Goehring, Gudrun
de Wreede, Liesbeth C.
van Biezen, Anja
Scheid, Christof
Volin, Liisa
Maertens, Johan
Finke, Juergen
Schaap, Nicolaas
Robin, Marie
Passweg, Jakob
Cornelissen, Jan
Beelen, Dietrich
Heuser, Michael
de Witte, Theo
Kroeger, Nicolaus
HAEMATOLOGICA, 2015, 100 (03) : 400 - 408
[45] Myeloid Clonal Infiltrate Identified With Next-Generation Sequencing in Skin Lesions Associated With Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: A Case Series
de Fremont, Gregoire Martin
Hirsch, Pierre
de Mestral, Santiago Gimenez
Moguelet, Philippe
Ditchi, Yoan
Emile, Jean-Francois
Senet, Patricia
Georgin-Lavialle, Sophie
Hanslik, Thomas
Maurier, Francois
Adedjouma, Amir
Abisror, Noemie
Mahevas, Thibault
Malard, Florent
Ades, Lionel
Fenaux, Pierre
Fain, Olivier
Chasset, Francois
Mekinian, Arsene
FRONTIERS IN IMMUNOLOGY, 2021, 12
[46] Distinct Genomic Associations to Predict Acute Myeloid Leukemia (AML) Progression from Myelodysplastic Syndromes (MDS)
Madanat, Yazan F.
Sekeres, Mikkael A.
Mukherjee, Sudipto
Al-Issa, Karam
Hirsch, Cassandra M.
Gerds, Aaron T.
Jha, Babal K.
Adema, Vera
Advani, Anjali
Nagata, Yasunobu
Kuzmanovic, Teodora
Carraway, Hetty E.
Przychodzen, Bartlomiej
Maciejewski, Jaroslaw P.
Nazha, Aziz
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S261 - S261
[47] Influence of Acute Myeloid Leukemia Progression on the Prognosis of 831 Patients With Myelodysplastic Syndromes From the Argentine Database
Enrico, Alicia
Bestach, Yesica
Flores, Maria Gabriela
Arbelbide, Jorge
Serale, Camila
Novoa, Viviana
Crisp, Renee
Rivas, Maria Marta
Larripa, Irene
Belli, Carolina
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (11): : 743 - +
[48] Acute myeloid leukemia cell lines MOLM-17 and MOLM-18 derived from patient with advanced myelodysplastic syndromes
Matsuo, Y
Drexler, HG
Harashima, A
Okochi, A
Kojima, K
Asakura, S
Tanimoto, M
Orita, K
LEUKEMIA RESEARCH, 2005, 29 (06) : 701 - 710
[49] Clonal hematopoiesis-derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders
Awada, Hussein
Gurnari, Carmelo
Visconte, Valeria
Durmaz, Arda
Kuzmanovic, Teodora
Awada, Hassan
Tu, Zheng Jin
Cook, James R.
Bolwell, Brian J.
Sobecks, Ronald
Kalaycio, Matt
Bosler, David
Maciejewski, Jaroslaw P.
LEUKEMIA, 2024, 38 (06) : 1266 - 1274
[50] Iron Chelation in Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms-Real-World Data from the German Noninterventional Study EXCALIBUR
Schulz, Felicitas
Hauch, Ulrich
Ketzler-Henkel, Sandra
von der Heyde, Eyck
Koenigsmann, Michael
Lauseker, Michael
Schulte, Nora
Germing, Ulrich
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)

← 1 2 3 4 5 →